CD19 + CD23+ B cells, CD4 + CD25+ T cells, E-selectin and interleukin-12 levels in children with steroid sensitive nephrotic syndrome

Italian Journal of Pediatrics

Volumn 39, Issue 1, 2013, Pages

  Yildiz, Bilal ^a   Cetin, Nuran ^a   Kural, Nurdan ^a   Colak, Omer ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Interleukin 12; sCD19 + CD23+ B cells; sCD4 + CD25+ T cells; sE selectin; Steroid sensitive nephrotic syndrome

Indexed keywords

CD19 ANTIGEN; CD23 ANTIGEN; CHOLESTEROL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN; INTERLEUKIN 12; TRIACYLGLYCEROL;

ARTICLE; B LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; LYMPHOCYTE SUBPOPULATION; MALE; NEPHROTIC SYNDROME; PERIPHERAL LYMPHOCYTE; PRESCHOOL CHILD; REGULATORY T LYMPHOCYTE; RELAPSE; REMISSION; SCHOOL CHILD; STEROID SENSITIVE NEPHROTIC SYNDROME;

ADOLESCENT; ANTIGENS, CD19; B-LYMPHOCYTES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; E-SELECTIN; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS; IMMUNOLOGIC FACTORS; INTERLEUKIN-12; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; NEPHROTIC SYNDROME; RECEPTORS, IGE; T-LYMPHOCYTES; TRIGLYCERIDES;

EID: 84879826249     PISSN: 17208424     EISSN: 18247288     Source Type: Journal    
DOI: 10.1186/1824-7288-39-42     Document Type: Article

References (24)

1. Evaluation of T lymphocyte subpopulations in children with nephroticsyndrome. Herrod HG, Stapleton FB, Trouy RL, Roy S, Clin Exp Immunol 1983 52 581 585 6603300 (Pubitemid 13089101)
2. Th1 and Th2 Cytokine mRNA profiles in childhood Nephrotic Syndrome evidence for Increased IL-13 mRNA expression in relapse. Yap HK, Cheung W, Murugasu B, Sim SK, Seah CC, Jordan SC, J Am Soc Nephrol 1999 10 529 537 10073603 (Pubitemid 29117634)
3. The immune system in minimal change nephrotic syndrome. Schnaper HW, Pediatr Nephrol 1989 3 101 110 10.1007/BF00859637 2702078 (Pubitemid 19043603)
4. Increased IL-2, IL-4, and interferon-gamma (IFN-) in steroid-sensitive nephrotic syndrome. Neuhaus TJ, Wadhwa M, Callard R, Barratt TM, Clin Exp Immunol 1995 100 475 479 7774059
5. Serum levels of immunoglobulins and IgG subclasses in steroid sensitive nephrotic syndrome. Kemper MJ, Altrogge H, Ganschow R, Muller-Wiefel DE, Pediatr Nephrol 2002 17 413 417 10.1007/s00467-001-0817-7 12107805 (Pubitemid 36067989)
6. T-lymphocyte populations and cytokines in childhood nephrotic syndrome. Lama G, Luongo I, Tirino G, Borriello A, Carangio C, Salsano ME, Am J Kidney Dis 2002 39 958 965 10.1053/ajkd.2002.32769 11979339 (Pubitemid 34454214)
7. T-lymphocyte activation in steroid-sensitive nephrotic syndrome in childhood. Neuhaus TJ, Shah V, Callard RE, Barratt TM, Nephrol Dial Transplant 1995 10 1348 1352 8538925
8. Transcriptional and post-transcriptional alterations of IkappaBalpha in active minimal-change nephrotic syndrome. Sahali D, Pawlak A, Le Gouvello S, Lang P, Valanciute A, Remy P, Loirat C, Niaudet P, Bensman A, Guellaen G, J Am Soc Nephrol 2001 12 1648 1658 11461937 (Pubitemid 32674427)
9. Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, Groothoff J, Llanas B, Niaudet P, Nivet H, Raynaud N, Taque S, Ronco P, Bouissou F, Pediatr Nephrol 2008 23 1269 1279 10.1007/s00467-008-0814-1 18465150
10. Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children. Kamei K, Ito S, Nozu K, Fujinaga S, Nakayama M, Sako M, Saito M, Yoneko M, Iijima K, Pediatr Nephrol 2009 24 1321 1328 10.1007/s00467-009-1191-0 19421786
11. Rituximab in refractory nephrotic syndrome. Prytula A, Iijima K, Kamei K, Geary D, Gottlich E, Majeed A, Taylor M, Marks SD, Tuchman S, Camilla R, Ognjanovic M, Filler G, Smith G, Tullus K, Pediatr Nephrol 2010 25 461 468 10.1007/s00467-009-1376-6 20033225
12. Treatment with Rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE. Vallerskog T, Gunnarsson I, Widhe M, Risselada A, Klareskog L, Van Vollenhoven R, Malmstrom V, Trollmo C, Clin Immunol 2007 122 62 74 10.1016/j.clim.2006.08.016 17046329 (Pubitemid 46026695)
13. FCER2: a pharmacogenetic basis for severe exacerbations in children with asthma. Tantisira KG, Silverman ES, Mariani TJ, Xu J, Richter BG, Klanderman BJ, et al. J Allergy Clin Immunol 2007 120 1285 91 10.1016/j.jaci.2007.09.005 17980418 (Pubitemid 350216603)
14. IgE, mast cells, basophils, and eosinophils. Stone KD, Prussin C, Metcalfe DD, J Allergy Clin Immunol 2010 125 73 80 10.1016/j.jaci.2009.11.017 20176269
15. Increased IL-12 release by monocytes in nephrotic patients. Matsumoto K, Kanmatsuse K, Clin Exp Immunol 1999 117 361 367 10.1046/j.1365-2249.1999.00975.x 10444271 (Pubitemid 29343611)
16. Increased interleukin-12 release from peripheral blood mononuclear cells in nephrotic phase of minimal change nephrotic syndrome. Lin CY, Chien JW, Acta Paediatr Taiwan 2004 45 77 80 15335115
17. Molecular cloning and characterization of murine IL-12 genes. Yoshimoto T, Kojima K, Funakoshi T, Endo Y, Fujita T, Nariuchi H, J Immunol 1996 156 1082 1088 8557982 (Pubitemid 26048101)
18. Interleukin-12: biological properties and clinical application. Del Vecchio M, Bajetta E, Canova S, Lotze MT, Wesa A, Parmiani G, Anichini A, Clin Cancer Res 2007 13 4677 85 10.1158/1078-0432.CCR-07-0776 17699845 (Pubitemid 47294773)
19. GATA-3 is upregulated in peripheral blood mononuclear cells from patients with minimal change nephrotic syndrome. Komatsuda A, Wakui H, Iwamoto K, Togashi M, Masai R, Maki N, Sawada K, Clin Nephrol 2009 71 608 16 19473628
20. Soluble forms of vascular adhesion molecules. E-selectin, ICAM-1 and VCAM-1: pathological significance. Gearing AJH, Hemingway I, Piggott R, Hughes J, Rees AJ, Cashman SJ, Ann NY Acad Sci 1992 667 324 331 10.1111/j.1749-6632. 1992.tb51633.x 1285023 (Pubitemid 23061599)
21. IL-4 and IL-13 downregulate rolling adhesion of leukocytes to IL-1 or TNF-activated endothelial cells by limiting the interval of E-selectin expression. Etter H, Althaus R, Eugster HP, Santamaria-Babi LF, Weber L, Moser R, Cytokine 1998 10 395 403 10.1006/cyto.1997.0308 9632524 (Pubitemid 28276784)
22. Interleukin 12 and interleukin 4 control T cell adhesion to endothelial selectins through opposite effects on {alpha}1,3-fucosyltransferase VII gene expression. Wagers AJ, Waters CM, Stoolman LM, Kansas GS, J Exp Med 1998 188 2225 2231 10.1084/jem.188.12.2225 9858509 (Pubitemid 29028495)
23. Effect of lipoproteins on cultured human mesangial cells. Nishida Y, Yorioka N, Oda H, Yamakido M, Am J Kidney Dis 1997 29 919 930 10.1016/S0272-6386(97)90467-4 9186079 (Pubitemid 27251846)
24. Hypercholesterolemia increases endothelial superoxide anion production. Ohara Y, Peterson TE, Harrison DG, J Clin Invest 1993 91 2546 51 10.1172/JCI116491 8390482 (Pubitemid 23182507)